• 7984.0
  • 54.3
  • 98.5
  • ICON

    Closing Price (c): 14696.0

  • RATING 01/05/14

  • PREVIOUS RATING 27/10/11


Company Profile

ICON plc is a full-service clinical research organisation (CRO) that provides a comprehensive range of clinical services in Phase I-IV clinical trials to the pharmaceutical, biotechnology and device industries. These services include clinical research, biometrics, interactive technologies, laboratory, clinical pharmacology and consulting services. They are offered on a global basis to clients from 69 locations in 39 countries worldwide.

Major Shareholders%
Neuberger Berman LLC 9.8
EARNEST Partners 9.0
AllianceBernstein 4.8
Wasatch Advisors Inc 4.7